NCT00138762
- Conditions
- Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
- Locations
-
- Pfizer Investigational Site Mobile, Alabama, United States
- Pfizer Investigational Site Mesa, Arizona, United States
- Pfizer Investigational Site Oro Valley, Arizona, United States
- Pfizer Investigational Site Phoenix, Arizona, United States